CCMG
CPRX

Clark Capital Management Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Clark Capital Management Group’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1M Buy
+568,676
New +$13.5M 0.09% 165
2025
Q3 		– Sell
-392,368
Closed -$8.51M – 449
2025
Q2 		$8.51M Buy
392,368
+147,373
+60% +$3.48M 0.06% 165
2025
Q1 		$5.94M Buy
244,995
+37,262
+18% +$839K 0.04% 178
2024
Q4 		$4.34M Buy
+207,733
New +$4.46M 0.03% 206
2024
Q1 		– Sell
-173,858
Closed -$2.92M – 396
2023
Q4 		$2.92M Sell
173,858
-25,211
-13% -$345K 0.02% 206
2023
Q3 		$2.33M Buy
199,069
+45,977
+30% +$615K 0.02% 205
2023
Q2 		$2.06M Buy
153,092
+10,643
+7% +$153K 0.02% 215
2023
Q1 		$2.36M Buy
+142,449
New +$2.35M 0.03% 198

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Clark Capital Management Group's CPRX Position: Q1 2026 in Review

Clark Capital Management Group opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 568,676 shares worth $14.1M. The stake represents 0.09% of the portfolio and ranks #165 among its holdings. This is a return to the name: Clark Capital Management Group previously reported a position in CPRX as recently as Q2 2025.

Clark Capital Management Group first reported a position in CPRX in Q1 2023 and has held it in 8 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Clark Capital Management Group held 568,676 shares of Catalyst Pharmaceutical worth $14.1M as of Q1 2026.
  • Catalyst Pharmaceutical was a new Clark Capital Management Group position in Q1 2026.
  • Catalyst Pharmaceutical made up 0.09% of Clark Capital Management Group's portfolio in Q1 2026, its #165 holding.
  • Clark Capital Management Group first reported a position in Catalyst Pharmaceutical in Q1 2023 and has held it in 8 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.